Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease

This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography ((18)F-FDG PET) in the post-therapy surveillance for patients with endometrial cancer showing no evidence of disease (NED). From April 1997 to June 2007, 127 patients with endometrial cancer showing NED were...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 25; no. 7; pp. 1029 - 1033
Main Authors Ryu, Sang-Young, Kim, Kidong, Kim, Younha, Park, Sang-Il, Kim, Beob-Jong, Kim, Moon-Hong, Choi, Seok-Cheol, Lee, Eui-Don, Lee, Kyung-Hee, Kim, Byung Il
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Medical Sciences 01.07.2010
대한의학회
Subjects
Adult
Aged
Endometrial Neoplasms - diagnosis
Endometrial Neoplasms - diagnostic imaging
Endometrial Neoplasms - pathology
Female
Fluorodeoxyglucose F18
Humans
Middle Aged
Neoplasm Recurrence, Local - diagnosis
Neoplasm Recurrence, Local - diagnostic imaging
Neoplasm Recurrence, Local - pathology
Original
Positron-Emission Tomography - methods
Predictive Value of Tests
Retrospective Studies
Sensitivity and Specificity
의학일반
Recurrence
Positron-Emission Tomography
Endometrial Neoplasms
Online AccessGet full text
ISSN1598-6357
1011-8934
1598-6357
DOI10.3346/jkms.2010.25.7.1029

Cover

Abstract This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography ((18)F-FDG PET) in the post-therapy surveillance for patients with endometrial cancer showing no evidence of disease (NED). From April 1997 to June 2007, 127 patients with endometrial cancer showing NED were performed (18)F-FDG PET scan. The feasibility of (18)F-FDG PET for the early detection of recurrence in patients with endometrial cancer was evaluated retrospectively. Of the 127 patients, 32 patients showed positive lesions on (18)F-FDG PET scan. Nineteen (19/127 cases, 15%) of them were confirmed to have a recurrence clinically or histologically. The sensitivity, specificity and positive and negative predictive value of (18)F-FDG PET for detecting recurrences in patients with endometrial cancer were 100%, 88%, 59% and 100%, respectively. In conclusion, (18)F-FDG PET may be a useful method for the post-therapy surveillance in patients with endometrial cancer.
AbstractList This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography ((18)F-FDG PET) in the post-therapy surveillance for patients with endometrial cancer showing no evidence of disease (NED). From April 1997 to June 2007, 127 patients with endometrial cancer showing NED were performed (18)F-FDG PET scan. The feasibility of (18)F-FDG PET for the early detection of recurrence in patients with endometrial cancer was evaluated retrospectively. Of the 127 patients, 32 patients showed positive lesions on (18)F-FDG PET scan. Nineteen (19/127 cases, 15%) of them were confirmed to have a recurrence clinically or histologically. The sensitivity, specificity and positive and negative predictive value of (18)F-FDG PET for detecting recurrences in patients with endometrial cancer were 100%, 88%, 59% and 100%, respectively. In conclusion, (18)F-FDG PET may be a useful method for the post-therapy surveillance in patients with endometrial cancer.
This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography ( 18 F-FDG PET) in the post-therapy surveillance for patients with endometrial cancer showing no evidence of disease (NED). From April 1997 to June 2007, 127 patients with endometrial cancer showing NED were performed 18 F-FDG PET scan. The feasibility of 18 F-FDG PET for the early detection of recurrence in patients with endometrial cancer was evaluated retrospectively. Of the 127 patients, 32 patients showed positive lesions on 18 F-FDG PET scan. Nineteen (19/127 cases, 15%) of them were confirmed to have a recurrence clinically or histologically. The sensitivity, specificity and positive and negative predictive value of 18 F-FDG PET for detecting recurrences in patients with endometrial cancer were 100%, 88%, 59% and 100%, respectively. In conclusion, 18 F-FDG PET may be a useful method for the post-therapy surveillance in patients with endometrial cancer.
This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography (18F-FDG PET) in the post-therapy surveillance for patients with endometrial cancer showing no evidence of disease (NED). From April 1997 to June 2007, 127 patients with endometrial cancer showing NED were performed 18F-FDG PET scan. The feasibility of 18F-FDG PET for the early detection of recurrence in patients with endometrial cancer was evaluated retrospectively. Of the 127 patients, 32 patients showed positive lesions on 18F-FDG PET scan. Nineteen (19/127 cases, 15%) of them were confirmed to have a recurrence clinically or histologically. The sensitivity, specificity and positive and negative predictive value of 18F-FDG PET for detecting recurrences in patients with endometrial cancer were 100%, 88%, 59% and 100%, respectively. In conclusion, 18F-FDG PET may be a useful method for the post-therapy surveillance in patients with endometrial cancer. KCI Citation Count: 3
This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography ((18)F-FDG PET) in the post-therapy surveillance for patients with endometrial cancer showing no evidence of disease (NED). From April 1997 to June 2007, 127 patients with endometrial cancer showing NED were performed (18)F-FDG PET scan. The feasibility of (18)F-FDG PET for the early detection of recurrence in patients with endometrial cancer was evaluated retrospectively. Of the 127 patients, 32 patients showed positive lesions on (18)F-FDG PET scan. Nineteen (19/127 cases, 15%) of them were confirmed to have a recurrence clinically or histologically. The sensitivity, specificity and positive and negative predictive value of (18)F-FDG PET for detecting recurrences in patients with endometrial cancer were 100%, 88%, 59% and 100%, respectively. In conclusion, (18)F-FDG PET may be a useful method for the post-therapy surveillance in patients with endometrial cancer.This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography ((18)F-FDG PET) in the post-therapy surveillance for patients with endometrial cancer showing no evidence of disease (NED). From April 1997 to June 2007, 127 patients with endometrial cancer showing NED were performed (18)F-FDG PET scan. The feasibility of (18)F-FDG PET for the early detection of recurrence in patients with endometrial cancer was evaluated retrospectively. Of the 127 patients, 32 patients showed positive lesions on (18)F-FDG PET scan. Nineteen (19/127 cases, 15%) of them were confirmed to have a recurrence clinically or histologically. The sensitivity, specificity and positive and negative predictive value of (18)F-FDG PET for detecting recurrences in patients with endometrial cancer were 100%, 88%, 59% and 100%, respectively. In conclusion, (18)F-FDG PET may be a useful method for the post-therapy surveillance in patients with endometrial cancer.
Author Lee, Eui-Don
Kim, Kidong
Ryu, Sang-Young
Park, Sang-Il
Kim, Younha
Kim, Moon-Hong
Kim, Beob-Jong
Lee, Kyung-Hee
Kim, Byung Il
Choi, Seok-Cheol
AuthorAffiliation 1 Department of Obstetrics & Gynecology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul, Korea
2 Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul, Korea
AuthorAffiliation_xml – name: 2 Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul, Korea
– name: 1 Department of Obstetrics & Gynecology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul, Korea
Author_xml – sequence: 1
  givenname: Sang-Young
  surname: Ryu
  fullname: Ryu, Sang-Young
  email: ryu@kcch.re.kr
  organization: Department of Obstetrics & Gynecology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea. ryu@kcch.re.kr
– sequence: 2
  givenname: Kidong
  surname: Kim
  fullname: Kim, Kidong
– sequence: 3
  givenname: Younha
  surname: Kim
  fullname: Kim, Younha
– sequence: 4
  givenname: Sang-Il
  surname: Park
  fullname: Park, Sang-Il
– sequence: 5
  givenname: Beob-Jong
  surname: Kim
  fullname: Kim, Beob-Jong
– sequence: 6
  givenname: Moon-Hong
  surname: Kim
  fullname: Kim, Moon-Hong
– sequence: 7
  givenname: Seok-Cheol
  surname: Choi
  fullname: Choi, Seok-Cheol
– sequence: 8
  givenname: Eui-Don
  surname: Lee
  fullname: Lee, Eui-Don
– sequence: 9
  givenname: Kyung-Hee
  surname: Lee
  fullname: Lee, Kyung-Hee
– sequence: 10
  givenname: Byung Il
  surname: Kim
  fullname: Kim, Byung Il
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20592894$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001453536$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNpVkU1PHDEMhiMEKl_9BUhVbu1llnxMJsmlEgIWkJBAaHuOMhkPG3Ym2SazIP59w0IrerItv35e2T5EuyEGQOiEkhnndXP6tBrzjJFSMjGTM0qY3kEHVGhVNVzI3U_5PjrM-YkQJgTjX9A-I0IzpesD5C9gAjf5GHDscQK3SQmCA9y-Yqrm1fziCt9fLrAPeG0nD2HK-MVPSwyhiyNMydsBO1smEs7L-OLDIw4Rw7PvtpgC7XwGm-EY7fV2yPD1Ix6hX_PLxfl1dXt3dXN-dlsFJvlUKe6AMXC9o7Lmum8Ua1gvmKbCAXXAW1AECCNcQOc06epa9US2tOet5lDzI_TjnRtSb1bOm2j9Nj5Gs0rm7GFxY4TkSqgi_fkuXW_asdDKdskOZp38aNPrdvD_TvDLgnk25XZESV0A3z8AKf7eQJ7M6LODYbAB4iYbybloJFVvym-frf55_P0E_wMQ5I6j
ContentType Journal Article
Copyright 2010 The Korean Academy of Medical Sciences. 2010
Copyright_xml – notice: 2010 The Korean Academy of Medical Sciences. 2010
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.3346/jkms.2010.25.7.1029
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1598-6357
EndPage 1033
ExternalDocumentID oai_kci_go_kr_ARTI_573858
PMC2890879
20592894
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
29K
2WC
3O-
5-W
53G
5GY
8JR
8XY
9ZL
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EBS
ECM
EF.
EIF
EJD
F5P
FRP
GROUPED_DOAJ
GX1
HYE
KQ8
M48
NPM
O5R
O5S
OK1
PGMZT
RNS
RPM
TR2
W2D
XSB
7X8
OVT
5PM
08R
ACYCR
M~E
ID FETCH-LOGICAL-n273t-83ce22ecfc17439f68262f52915ce1ce3be80e02035edc90d448f07b1f3b93e43
IEDL.DBID M48
ISSN 1598-6357
1011-8934
IngestDate Tue Nov 21 21:47:43 EST 2023
Thu Aug 21 18:18:47 EDT 2025
Fri Jul 11 12:22:56 EDT 2025
Thu Apr 03 07:09:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Recurrence
Positron-Emission Tomography
Endometrial Neoplasms
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-n273t-83ce22ecfc17439f68262f52915ce1ce3be80e02035edc90d448f07b1f3b93e43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0191120100250071029
G704-000345.2010.25.7.004
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2010.25.7.1029
PMID 20592894
PQID 733567189
PQPubID 23479
PageCount 5
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_573858
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2890879
proquest_miscellaneous_733567189
pubmed_primary_20592894
PublicationCentury 2000
PublicationDate 2010-07-01
PublicationDateYYYYMMDD 2010-07-01
PublicationDate_xml – month: 07
  year: 2010
  text: 2010-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of Korean medical science
PublicationTitleAlternate J Korean Med Sci
PublicationYear 2010
Publisher The Korean Academy of Medical Sciences
대한의학회
Publisher_xml – name: The Korean Academy of Medical Sciences
– name: 대한의학회
References 11606090 - Gynecol Oncol. 2001 Nov;83(2):310-5
17204718 - J Nucl Med. 2007 Jan;48 Suppl 1:28S-35S
16167154 - Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):36-44
8657901 - Radiology. 1996 Jul;200(1):135-41
12192557 - Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1132-9
16556457 - Gynecol Oncol. 2006 Jun;101(3):520-9
11041682 - Int J Gynaecol Obstet. 2000 Aug;70(2):209-62
8055452 - Cancer. 1994 Aug 15;74(4):1303-8
11933681 - J Reprod Med. 2002 Mar;47(3):173-89; discussion 189-90
17106701 - Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):472-9
6693055 - Gynecol Oncol. 1984 Jan;17(1):85-103
8153308 - Radiology. 1994 May;191(2):371-7
12846541 - Ann Nucl Med. 2003 May;17(3):197-203
10405131 - J Nucl Med. 1999 Jul;40(7):1125-31
12620999 - J Nucl Med. 2003 Mar;44(3):347-52
10624770 - Eur Respir J. 1999 Dec;14(6):1376-80
References_xml – reference: 6693055 - Gynecol Oncol. 1984 Jan;17(1):85-103
– reference: 10624770 - Eur Respir J. 1999 Dec;14(6):1376-80
– reference: 12846541 - Ann Nucl Med. 2003 May;17(3):197-203
– reference: 8153308 - Radiology. 1994 May;191(2):371-7
– reference: 12620999 - J Nucl Med. 2003 Mar;44(3):347-52
– reference: 11041682 - Int J Gynaecol Obstet. 2000 Aug;70(2):209-62
– reference: 12192557 - Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1132-9
– reference: 8055452 - Cancer. 1994 Aug 15;74(4):1303-8
– reference: 11933681 - J Reprod Med. 2002 Mar;47(3):173-89; discussion 189-90
– reference: 8657901 - Radiology. 1996 Jul;200(1):135-41
– reference: 11606090 - Gynecol Oncol. 2001 Nov;83(2):310-5
– reference: 17106701 - Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):472-9
– reference: 10405131 - J Nucl Med. 1999 Jul;40(7):1125-31
– reference: 16167154 - Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):36-44
– reference: 16556457 - Gynecol Oncol. 2006 Jun;101(3):520-9
– reference: 17204718 - J Nucl Med. 2007 Jan;48 Suppl 1:28S-35S
SSID ssj0025523
Score 1.9490129
Snippet This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography ((18)F-FDG PET) in the post-therapy surveillance for patients with...
This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography ( 18 F-FDG PET) in the post-therapy surveillance for patients with...
This study assessed the feasibility of F-18-fluorodeoxyglucose positron-emission tomography (18F-FDG PET) in the post-therapy surveillance for patients with...
SourceID nrf
pubmedcentral
proquest
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1029
SubjectTerms Adult
Aged
Endometrial Neoplasms - diagnosis
Endometrial Neoplasms - diagnostic imaging
Endometrial Neoplasms - pathology
Female
Fluorodeoxyglucose F18
Humans
Middle Aged
Neoplasm Recurrence, Local - diagnosis
Neoplasm Recurrence, Local - diagnostic imaging
Neoplasm Recurrence, Local - pathology
Original
Positron-Emission Tomography - methods
Predictive Value of Tests
Retrospective Studies
Sensitivity and Specificity
의학일반
Title Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease
URI https://www.ncbi.nlm.nih.gov/pubmed/20592894
https://www.proquest.com/docview/733567189
https://pubmed.ncbi.nlm.nih.gov/PMC2890879
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001453536
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Korean Medical Science, 2010, 25(7), 140, pp.1029-1033
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwELVKkRAXxDfLx8pIXFMltpPYB4QQ7dKCFnHoSr1ZsXdMV9s6kGwF_ffMONmKovaUQxJHGdua9_Imbxh712AWEMHrzCnQmXK4FRtXqaxUstZVHVye3Pbn36rDhfpyUp7ssG1X1DGA_Y3UjvpJLbqzvT-_Lj_ghn9PjFOSQrk-74ciLVHu1WRGYO6wu5iaKmJjc3UlKyB8FnKwHrrtRjIHRsSBNERhtolduAl5_l9A-U9Gmj1kD0YoyT8Oc_-I7UB8zO7NR7H8CVvtwyYVWkXeBt7Rh_X0ax93l7zQs2y2_5l_Pzjmq8hHd9We02dZDnHZnkPq58E9rYqO96ftb0xyPLYcxj6kNOgo7zxli9nB8afDbOyskEWEK5tMSw9CgA8-EZJQIckQoRSmKD0UHqQDnQOJlCW-pMmXSOJCXrsiSGckKPmM7cY2wgvGKxC5kVo0Ta0VmCXimdy7XJvQFN5rP2FvMYp27VeWnKzp-KO1684iXj-yZTLTmTC-jbHF1U2SRROhvehtLWVZYfo0E_Z8CLn9Obhw2O00TVh9bTKuLqDHXT8TV6fJQJvEVV2bl7eO-YrdH6oEqCz3NdvddBfwBsHHxk0Rdh99nSbqPk2L6y8Li9k5
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detection+of+recurrence+by+18F-FDG+PET+in+patients+with+endometrial+cancer+showing+no+evidence+of+disease&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Ryu%2C+Sang-Young&rft.au=Kim%2C+Kidong&rft.au=Kim%2C+Younha&rft.au=Park%2C+Sang-Il&rft.date=2010-07-01&rft.eissn=1598-6357&rft.volume=25&rft.issue=7&rft.spage=1029&rft_id=info:doi/10.3346%2Fjkms.2010.25.7.1029&rft_id=info%3Apmid%2F20592894&rft.externalDocID=20592894
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-6357&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-6357&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-6357&client=summon